THE ADVERSE-EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY

被引：0
|
作者：
WONG, KC [1 ]
LI, PKT [1 ]
LUI, SF [1 ]
NICHOLLS, MG [1 ]
LAI, KN [1 ]
机构：
[1] CHINESE UNIV HONG KONG, DEPT MED, SHA TIN, HONG KONG
来源：
ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS | 1990年 / 9卷 / 04期
关键词：
UREMIA; ANEMIA; DIALYSIS; ERYTHROPOIETIN; ADVERSE EFFECTS;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：183 / 206
页数：24
相关论文
共 50 条
  • [41] RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) FOR TREATMENT OF MYELODYSPLASTIC SYNDROME
    ZEIGLER, ZR
    JONES, D
    ROSENFELD, CS
    SHADDUCK, RK
    STEM CELLS, 1993, 11 (01) : 49 - 55
  • [42] RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHEPO) ADMINISTRATION MARROW DONORS
    AKIYAMA, H
    TANIKAWA, S
    TAKAMOTO, S
    SAKAMAKI, H
    SASAKI, T
    ONOZAWA, Y
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1995, 62 (03) : 145 - 149
  • [43] DOSE-DEPENDENT EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON THE RETICULOCYTE POPULATION OF RABBITS
    FUCHS, A
    EDER, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-2 (10): : 1266 - 1268
  • [44] EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AND INTERLEUKIN-3 ON ERYTHROPOIETIC RECOVERY FROM ACUTE ANEMIA
    ROSEN, BS
    LEVINE, EA
    EGRIE, JC
    SEHGAL, LR
    GREENBERG, R
    ROSEN, AL
    LEVINE, HD
    GOULD, SA
    EXPERIMENTAL HEMATOLOGY, 1993, 21 (11) : 1487 - 1491
  • [45] EFFECT OF RECOMBINANT-HUMAN-ERYTHROPOIETIN ON HUMAN IGE PRODUCTION INVITRO
    KIMATA, H
    YOSHIDA, A
    ISHIOKA, C
    MIKAWA, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 83 (03) : 483 - 487
  • [46] EFFECTS OF DOSE, PH AND OSMOLARITY ON INTRANASAL ABSORPTION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN IN RATS
    SHIMODA, N
    MAITANI, Y
    MACHIDA, Y
    NAGAI, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 1995, 18 (05) : 734 - 739
  • [47] IS RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN MYELODYSPLASTIC SYNDROMES WORTHWHILE
    SPIRITI, MAA
    PETTI, MC
    LATAGLIATA, R
    AVVISATI, G
    DEGREGORIS, C
    PROIA, S
    FAZI, P
    JAALOUK, G
    MANCINI, M
    SPADEA, A
    VILLA, R
    MANDELLI, F
    LEUKEMIA & LYMPHOMA, 1993, 9 (1-2) : 79 - 83
  • [48] RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AND MYELOFIBROSIS
    MOHR, B
    HERRMANN, R
    HUHN, D
    ACTA HAEMATOLOGICA, 1993, 90 (02) : 65 - 70
  • [49] COST OF TREATING PREDIALYSIS PATIENTS WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN
    DURANDZALESKI, I
    GOLDFARB, B
    BLUMBOISGARD, C
    DRUEKE, T
    KREIS, H
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (04) : 311 - 314
  • [50] EVIDENCE-BASED RECOMMENDATIONS FOR THE CLINICAL USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    MUIRHEAD, N
    BARGMAN, J
    BURGESS, E
    JINDAL, KK
    LEVIN, A
    NOLIN, L
    PARFREY, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (02) : S1 - S24
12345